New tuberculosis tools are here: can we deliver them for maximal impact?
作者信息
Pai Madhukar, Memish Ziad A
出版信息
J Epidemiol Glob Health. 2013 Mar;3(1):1-2. doi: 10.1016/j.jegh.2013.02.001. Epub 2013 Mar 15.
Abstract
摘要
相似文献
1
New tuberculosis tools are here: can we deliver them for maximal impact?新型结核病防治工具已问世：我们能否将其推广以实现最大影响？
J Epidemiol Glob Health. 2013 Mar;3(1):1-2. doi: 10.1016/j.jegh.2013.02.001. Epub 2013 Mar 15.
2
[Report of the VIth Tuberculosis Day Conference].[第六届世界防治结核病日会议报告]
Przegl Epidemiol. 2012;66(2):381-3.
3
Tuberculosis: a forgotten plague?结核病：一种被遗忘的瘟疫？
J R Soc Med. 2011 May;104(5):182-4. doi: 10.1258/jrsm.2011.100384.
4
Public enemy number one.头号公敌。
Science. 2013 Apr 26;340(6131):422-5. doi: 10.1126/science.340.6131.422.
5
Progress and challenges in childhood tuberculosis.儿童结核病的进展与挑战
Lancet Infect Dis. 2013 Apr;13(4):287-9. doi: 10.1016/S1473-3099(13)70031-8. Epub 2013 Mar 24.
6
[Childhood tuberculosis].[儿童结核病]
Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):168-80. doi: 10.1016/j.pneumo.2014.03.006. Epub 2014 Jun 3.
7
Cutting-edge science and the future of tuberculosis control.前沿科学与结核病控制的未来。
Bull World Health Organ. 2007 May;85(5):410-2. doi: 10.2471/06.035386.
8
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.发展中世界的结核病：诊断方面的最新进展，特别考虑广泛耐药结核病
Curr Opin Infect Dis. 2008 Oct;21(5):454-61. doi: 10.1097/QCO.0b013e32830ce783.
9
Update on tuberculosis: TB in the early 21st century.结核病最新情况：21世纪初的结核病
Eur Respir Rev. 2011 Jun;20(120):71-84. doi: 10.1183/09059180.00000511.
10
Zero deaths from tuberculosis: progress, reality, and hope.结核病零死亡：进展、现实与希望。
Lancet Infect Dis. 2013 Apr;13(4):285-7. doi: 10.1016/S1473-3099(13)70039-2. Epub 2013 Mar 24.
引用本文的文献
1
Measuring and improving the quality of tuberculosis care: A framework and implications from the Commission.衡量与改善结核病护理质量：委员会的框架及启示
J Clin Tuberc Other Mycobact Dis. 2019 Aug;16:100112. doi: 10.1016/j.jctube.2019.100112.
本文引用的文献
1
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核和利福平耐药性的Xpert® MTB/RIF检测
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
2
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.新型结核疫苗 MVA85A 在既往接种过卡介苗婴儿中的安全性和有效性：一项随机、安慰剂对照的 2b 期试验。
Lancet. 2013 Mar 23;381(9871):1021-8. doi: 10.1016/S0140-6736(13)60177-4.
3
New tuberculosis technologies: challenges for retooling and scale-up.新型结核病防治技术：重新配置和扩大规模面临的挑战。
Int J Tuberc Lung Dis. 2012 Oct;16(10):1281-90. doi: 10.5588/ijtld.12.0391.
4
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.PA-824、贝达喹啉、吡嗪酰胺和莫西沙星联合治疗的 14 天杀菌活性：一项随机试验。
Lancet. 2012 Sep 15;380(9846):986-93. doi: 10.1016/S0140-6736(12)61080-0. Epub 2012 Jul 23.
5
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.随机先导试验：使用贝达喹啉（TMC207）治疗 8 周治疗耐多药结核病：长期结果、耐受性和对耐药性出现的影响。
Antimicrob Agents Chemother. 2012 Jun;56(6):3271-6. doi: 10.1128/AAC.06126-11. Epub 2012 Mar 5.
6
The population dynamics and control of tuberculosis.结核病的种群动态与控制。
Science. 2010 May 14;328(5980):856-61. doi: 10.1126/science.1185449.
7
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.更有效的结核病疫苗、药物和诊断方法的流行病学益处。
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13980-5. doi: 10.1073/pnas.0901720106. Epub 2009 Aug 3.
Zotero 插件